CA2852591C - Compositions de vitamine d3 et ses utilisations pour le traitement des voies nasales - Google Patents

Compositions de vitamine d3 et ses utilisations pour le traitement des voies nasales Download PDF

Info

Publication number
CA2852591C
CA2852591C CA2852591A CA2852591A CA2852591C CA 2852591 C CA2852591 C CA 2852591C CA 2852591 A CA2852591 A CA 2852591A CA 2852591 A CA2852591 A CA 2852591A CA 2852591 C CA2852591 C CA 2852591C
Authority
CA
Canada
Prior art keywords
vitamin
nasal
ionic strength
sinus
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2852591A
Other languages
English (en)
Other versions
CA2852591A1 (fr
Inventor
Sam BARBALATT
Mark Harold WELFORD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ENT TECHNOLOGIES Pty Ltd
Original Assignee
ENT TECHNOLOGIES Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011900321A external-priority patent/AU2011900321A0/en
Application filed by ENT TECHNOLOGIES Pty Ltd filed Critical ENT TECHNOLOGIES Pty Ltd
Publication of CA2852591A1 publication Critical patent/CA2852591A1/fr
Application granted granted Critical
Publication of CA2852591C publication Critical patent/CA2852591C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H35/00—Baths for specific parts of the body
    • A61H35/04—Baths for specific parts of the body for the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur un procédé de traitement d'un tissu des muqueuses de voies nasales et de cavités sinusales paranasales d'un individu, lequel procédé comprend l'étape consistant à effectuer une administration topique d'une quantité thérapeutique de vitamines D3 dans un grand volume de solution d'administration à force ionique ultra faible.
CA2852591A 2011-02-02 2012-02-01 Compositions de vitamine d3 et ses utilisations pour le traitement des voies nasales Active CA2852591C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2011900321A AU2011900321A0 (en) 2011-02-02 Methods and Compositions for the Treatment of Nasal Mucosa
AU2011900321 2011-02-02
PCT/AU2012/000074 WO2012103575A1 (fr) 2011-02-02 2012-02-01 Compositions et procédés pour le traitement de voies nasales

Publications (2)

Publication Number Publication Date
CA2852591A1 CA2852591A1 (fr) 2013-08-09
CA2852591C true CA2852591C (fr) 2019-02-12

Family

ID=46602000

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2852591A Active CA2852591C (fr) 2011-02-02 2012-02-01 Compositions de vitamine d3 et ses utilisations pour le traitement des voies nasales

Country Status (3)

Country Link
AU (1) AU2012212385B2 (fr)
CA (1) CA2852591C (fr)
WO (1) WO2012103575A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937213A1 (fr) * 2014-01-28 2015-08-06 Resdevco Research And Development Co. Ltd. Composition comprenant du xylitol et du cholecalciferol pour traitement topique de la peau et des membranes muqueuses
MY200434A (en) 2016-02-17 2023-12-26 Ent Tech Pty Ltd Compositions and methods for the treatment of sinus disease and disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4919597A (en) * 1996-10-31 1998-05-22 American Home Products Corporation Synergistic composition comprising rapamycin and calcitriol
CA2571449C (fr) * 2004-06-25 2015-12-08 John Nikolaj Hvarre Christensen Compositions comprenant du strontium et de la vitamine d et utilisation de ces compositions
WO2008073174A2 (fr) * 2006-09-08 2008-06-19 The Regents Of The University Of California Thérapie antimicrobienne

Also Published As

Publication number Publication date
CA2852591A1 (fr) 2013-08-09
AU2012212385A1 (en) 2013-02-07
AU2012212385B2 (en) 2015-01-15
WO2012103575A1 (fr) 2012-08-09

Similar Documents

Publication Publication Date Title
US9844580B2 (en) Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis
US11154578B2 (en) Compositions and methods of use
CN107899006A (zh) 冲洗鼻腔的药物组合物及其制备方法
CN105147771A (zh) 一种透明质酸鼻腔冲洗液及其制备方法和应用
CA2852591C (fr) Compositions de vitamine d3 et ses utilisations pour le traitement des voies nasales
Harvey et al. Current concepts in topical therapy for chronic sinonasal disease.
US20220193174A1 (en) Nasal spray for preventing influenza based on red pepper extract and heparin and preparation method thereof
US20040116521A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
EP4364731B1 (fr) Composition avec de l'acide hyaluronique et du xylitol destinée à être utilisée dans le traitement de la muqueuse nasale et de la barrière épithéliale nasale altérée
US8940319B2 (en) Formulations, devices and methods for treating and preventing mucositis
US20120021060A1 (en) Honey Compositions and Uses Thereof
CN106232117A (zh) 鼻和鼻窦清洗组合物及方法
CN115414325A (zh) 一种纳米银鼻腔护理灭菌液及其制备方法及其应用
US12485093B2 (en) Composition for use as an antiviral in the form of nasal drops and in nebulisers
AU2023228847B2 (en) Treatment composition for nasal and oral dryness, nosebleeds, and allergy symptoms
JP6232631B2 (ja) 生体皮膜剤
CN117693352A (zh) 针对气道疾病的谷胱甘肽c4
CA2710701A1 (fr) Compositions de miel et leurs utilisations
WO2004080427A2 (fr) Methode de prevention et de traitement d'infections attaquant la muqueuse et d'aide a la readaptation ulterieure au moyen d'acide ascorbique applique localement
Kaliner 15 Adjuvant Therapies in the Treatment of Acute and Chronic Rhinosinusitis Mark D. Scarupa Institute for Asthma and Allergy, Johns Hopkins Asthma and Allergy Center, Chevy Chase, Maryland, USA
NZ728460B2 (en) Compositions comprising honey, a preservative and an aqueous carrier and methods of use
AU2015204387A1 (en) Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20161215

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250124

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250124

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250124

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD

Year of fee payment: 14

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251203

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251203